Welcome to the GENT board. GENT has the first drug for VOD.

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Welcome to the GENT board. GENT has the first drug for VOD.

An SI Board Since July 2006

Posts	SubjectMarks	Bans	Symbol
408	17	0	GENT

Emcee: rareearth42	Type: Moderated

Introduction Market Data Compact

GENT is a microcap biotech company, based in Italy, with a purified DNA drug called defibrotide, which has been studied extensively in VOD and really seems to work. At the time I created this board, it's in phase 3 in the US for treatment of VOD, and in phase 3 in Europe for prevention of VOD. VOD is veno-occlusive disease, an often-fatal complication of hematopoietic cell transplantation. It seems to be more common now than previously, which is coincident with the increase in peripheral stem cell transplant, but also there are other drugs used now, such as hematopoietic growth factors, that might also be implicated. Regardless, if this drug works it's a shoo-in for approval and use, and it will command a premium price.

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
408	Your ordinary shares (if you had requested them) would’ve been subject to a “squ	DewDiligence_on_SI	-	6/27/2014
407	I thought it was too complicated for me to get the ordinary shares and deal with	ghmm	-	6/27/2014
406	What would be the point of converting the ADRs to ordinary shares and then havin	DewDiligence_on_SI	-	6/27/2014
405	I was given the option to receive the underlying security of the ADR. Here is t	ghmm	-	6/27/2014
404	In one account I had the option to request the shares but I declined. I didn	DewDiligence_on_SI	-	6/27/2014
403	For anyone interested following this thread I had the last of my shares liquidat	ghmm	-	6/27/2014
402	>> from visual sophistication << From visual inspection, even. :-)	scaram(o)uche	-	6/10/2014
401	I had a chance (thanks, rkrw!) to take a stroll in an EKSO suit yesterday, using	scaram(o)uche	2	6/10/2014
400	Thanks for that info :-(	ghmm	-	1/31/2014
399	The holding period is one year plus one day for LT capital-gains treatment.	DewDiligence_on_SI	-	1/31/2014
398	The wording makes me a bit nervous. I only have to go to the 26th & 28th for	ghmm	-	1/31/2014
397	So you're home free?	tom pope	-	1/31/2014
396	If I understand this correctly those who haven't sold their ADS will get 90	ghmm	-	1/31/2014
395	It seems Jazz is really trying to reduce dependence on Xyrem. Given where the s	ghmm	-	1/23/2014
394	What I heard was a lot of the big GENT holders are also JAZZ holders, so what is	rkrw	-	1/23/2014
393	Jazz got their minimium finance.yahoo.com For me the good news is they extended	ghmm	-	1/23/2014
392	FYI it looks like they began trading under the symbol EKSO. I can't find an	ghmm	-	1/19/2014
391	actually, quite plausible.	tom pope	-	1/16/2014
390	Perhaps the surreptitious purpose of the lawsuit to is delay consummation of the	DewDiligence_on_SI	-	1/16/2014
389	In addition to what rkrw wrote, this could gum up the works and delay the closin	tom pope	-	1/16/2014
388	These are just extortion suits. Cookie cutter settlements of a few $100k. No one	rkrw	-	1/15/2014
387	Looks like a lawyer initiated suit on behalf of stockholders (wink wink). The a	fred hayes	-	1/15/2014
386	Here's a funny one - jumping the gun a bit - <i>Jazz Pharmaceuticals,	tom pope	-	1/15/2014
385	Haven't found out who the plaintiffs are yet, have you? Seems to have knocke	tom pope	-	1/15/2014
384	lawsuit...eom	fred hayes	-	1/15/2014

Go to reply# or date (mm/dd/yy):